Filing Details
- Accession Number:
- 0000921503-13-000094
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-03 16:13:57
- Reporting Period:
- 2013-08-30
- Filing Date:
- 2013-09-03
- Accepted Time:
- 2013-09-03 16:13:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
921503 | Blyth Inc | BTH | Pharmaceutical Preparations (2834) | 362984916 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1558227 | Ryan Blair | C/O Blyth, Inc. 1 East Weaver Street Greenwich CT 06831 | Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common | Acquisiton | 2013-08-30 | 20,000 | $9.15 | 320,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Represents a weighted average purchase price for transactions reported on this date. The range of prices for transactions reported in this line is: $9.11 to $9.23. The reporting person undertakes to provide upon request by the Securites and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.